Viking Therapeutics' highly anticipated readout of its oral anti-obesity pill showed a placebo-adjusted weight loss of 6.8% after four weeks, sticking the biotech near the front of ...
The demand for bariatric operations dropped sharply last year as use of anti-obesity drugs such as Wegovy surged, study finds ...
13don MSN
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
In July, the company changed tactics on its weight loss drug, cutting the daily dose from two to one. The company is currently engaged in clinical trials on danuglipron, with results expected to ...
A new study suggests that GLP-1 agonist medications ... by the U.S. Food and Drug Administration for that purpose, Fitch pointed out. RELATED: Popular weight-loss and diabetes medications linked ...
Despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, fewer than one in ... [+] five large employers are covering such prescriptions, a new KFF analysis shows. In this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback